Axcelis Technologies, Inc. $ACLS Stock Position Decreased by ProShare Advisors LLC

ProShare Advisors LLC reduced its position in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 39.5% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 8,467 shares of the semiconductor company’s stock after selling 5,534 shares during the period. ProShare Advisors LLC’s holdings in Axcelis Technologies were worth $1,111,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wellington Management Group LLP purchased a new position in shares of Axcelis Technologies in the second quarter valued at $13,070,000. The Manufacturers Life Insurance Company boosted its position in shares of Axcelis Technologies by 3,402.5% in the 1st quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company’s stock worth $45,772,000 after buying an additional 477,705 shares in the last quarter. Reinhart Partners LLC. boosted its position in shares of Axcelis Technologies by 14.2% in the 3rd quarter. Reinhart Partners LLC. now owns 1,060,636 shares of the semiconductor company’s stock worth $139,134,000 after buying an additional 131,976 shares in the last quarter. Entropy Technologies LP acquired a new stake in Axcelis Technologies in the 1st quarter valued at about $1,004,000. Finally, Segall Bryant & Hamill LLC grew its stake in Axcelis Technologies by 96.1% in the 1st quarter. Segall Bryant & Hamill LLC now owns 200,371 shares of the semiconductor company’s stock valued at $18,651,000 after acquiring an additional 98,184 shares during the last quarter. 89.98% of the stock is owned by institutional investors and hedge funds.

Axcelis Technologies Trading Up 10.3%

ACLS opened at $99.24 on Friday. Axcelis Technologies, Inc. has a 52-week low of $73.60 and a 52-week high of $193.78. The company has a quick ratio of 3.21, a current ratio of 4.43 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $3.06 billion, a P/E ratio of 29.54, a P/E/G ratio of 3.03 and a beta of 1.88. The firm’s 50 day moving average is $115.62 and its 200-day moving average is $122.71.

Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings data on Thursday, November 5th. The semiconductor company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.15. Axcelis Technologies had a net margin of 11.74% and a return on equity of 11.51%. The company had revenue of $237.78 million during the quarter, compared to analyst estimates of $230.08 million. During the same period last year, the business earned $1.21 EPS. The firm’s revenue for the quarter was up 11.3% compared to the same quarter last year. Axcelis Technologies has set its Q4 2026 guidance at 1.500-1.500 EPS. Analysts expect that Axcelis Technologies, Inc. will post 3.39 EPS for the current fiscal year.

Axcelis Technologies News Summary

Here are the key news stories impacting Axcelis Technologies this week:

• Positive Sentiment: Third-quarter earnings beat expectations: non-GAAP EPS was $1.26 versus a $1.11 consensus, while revenue of $237.8 million topped estimates of about $230 million and rose 11.3% year over year. Axcelis Announces Financial Results for Third Quarter 2026
• Positive Sentiment: Axcelis forecast fourth-quarter revenue of $275 million and EPS of $1.50, both well above analyst estimates of roughly $239 million and $1.18, respectively. The upbeat outlook is a key reason for the positive investor reaction. Axcelis expects about $275M Q4 revenue
• Positive Sentiment: Craig Hallum upgraded ACLS from Hold to Buy and set a $140 price target, signaling improved analyst sentiment. Craig Hallum upgrades Axcelis
• Neutral Sentiment: Axcelis said it is targeting completion of its Veeco merger by the end of the first quarter of 2027; the transaction’s eventual impact will depend on closing and integration. Merger timing and Q4 outlook
• Negative Sentiment: B. Riley reaffirmed its Buy rating but cut its price target to $140 from $165, tempering the bullish signal despite the target remaining above the current share price. B. Riley reaffirms Buy and lowers target

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Weiss Ratings upgraded shares of Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, October 16th. Craig Hallum raised shares of Axcelis Technologies from a “hold” rating to a “buy” rating and set a $140.00 price target on the stock in a report on Friday. B. Riley Financial reiterated a “buy” rating and issued a $140.00 price target (down from $165.00) on shares of Axcelis Technologies in a research report on Friday. Finally, Wall Street Zen upgraded shares of Axcelis Technologies from a “hold” rating to a “buy” rating in a research report on Saturday. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $145.33.

About Axcelis Technologies

Axcelis Technologies, Inc develops and manufactures equipment used in the fabrication of semiconductor devices. The company is best known for its ion implantation systems, which precisely introduce dopant atoms into silicon wafers to control the electrical properties of semiconductor components.

Its product portfolio includes the Purion family of ion implantation systems, designed for applications such as high-current, medium-current and high-energy implantation. Axcelis also provides related aftermarket products and services, including spare parts, equipment upgrades, process support and customer training.

Headquartered in Beverly, Massachusetts, Axcelis serves semiconductor manufacturers and other customers in major chip-production regions worldwide.